Skip to main content Skip to navigation
We care about your privacy. Read about your rights and how we protect your data. Get Details

Coronavirus Update:What patients and families need to know

The Children's National Research Institute

Research Profile

Education & Training

  • Fellowship Program, Allergy/Immunology, Children's Hospital of Philadelphia, Philadelphia, PA (2013)
  • Residency Program, Pediatrics, Johns Hopkins Hospital, Baltimore, MD (2010)
  • Internship Program, Pediatrics, Johns Hopkins Hospital, Baltimore, MD (2008)
  • M.D., Duke University School of Medicine, Durham, NC (2007)
  • B.S., University of Virginia, Charlottesville, VA (2002)

Academic Appointments

  • Assistant Professor of Pediatrics, George Washington University School of Medicine and Health Sciences

Biography

Michael Keller, M.D., is a pediatric immunologist at Children's National Hospital and specializes in the diagnosis and treatment of primary and secondary immunodeficiency disorders. He has authored many peer-reviewed articles and contributed to expert consensus guidelines on the treatment and diagnosis of primary immunodeficiency disorders. Dr. Keller is a member of the American Academy of Allergy, Asthma, and Immunology (AAAAI); the Clinical Immunology Society; the European Society of Immunodeficiency; and the Primary Immunodeficiency Treatment Consortium (PIDTC).  

Dr. Keller's research focuses on the use of adoptive T-cell therapies for treatment of infections in immunocompromised patients, including the use of this therapy to improve outcomes in children with primary immunodeficiency disorders as well as those undergoing bone marrow transplantation for cancer. He is the primary investigator of several Phase I-II studies of virus-specific T-cell immunotherapy.

Dr. Keller lives in Maryland with his wife and two sons, and enjoys travel, hiking and martial arts.

This faculty member (or a member of their immediate family) has a working relationship (i.e. consulting, research, and/or educational services) with the companies listed below. These relations have been reported to the health system leadership and, when appropriate, management plans are in place to address potential conflicts.

Outside Interests

  • HZNP USA Inc. 

Research & Publications